Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

NCT04580485

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +59 more
Locations
  • Cedars-Sinai Medical Center West Hollywood, California, United States
  • University of Maryland-Greenebaum Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View all 27 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India

NCT04513522

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +8 more
Locations
  • Local Institution - 0005 Ahmedabad, Gujarat, India
  • Local Institution - 0011 Trivandrum, Kerala, India
  • Local Institution - 0013 Mumbai, Maharashtra, India
  • Local Institution - 0001 Mumbai, Maharashtra, India
View Trial Details
Completed

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

NCT03884556

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +27 more
Locations
  • UC Irvine Cancer Center Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 16 locations
View Trial Details
Completed

A Study of CDX-585 in Patients With Advanced Malignancies

NCT05788484

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +64 more
Locations
  • George Washington University Cancer Center Washington D.C., District of Columbia, United States
  • AdventHealth Celebration Celebration, Florida, United States
  • Perlmutter Cancer Center at NYU Langone Health New York, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

AURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCC

NCT04006405

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • UZ Leuven Leuven, Belgium
View all 29 locations
View Trial Details
Completed

Partial Nephrectomy in Low Pressure

NCT05404685

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • CHU d'Angers Angers, France
  • Centre Hospitalier Universitaire de Bordeaux Bordeaux, France
  • CHU de Caen Caen, France
  • Hopital Henri-Mondor Créteil, France
View all 15 locations
View Trial Details
Completed

To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

NCT05253053

Conditions
Adenocarcinoma, Advanced Solid Tumor, Biliary Tract Cancer, +56 more
Locations
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Hunan Cancer Hospital Changsha, Hunan, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
View Trial Details

Related conditions